These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16508954)

  • 21. The FMR1 premutation and reproduction.
    Wittenberger MD; Hagerman RJ; Sherman SL; McConkie-Rosell A; Welt CK; Rebar RW; Corrigan EC; Simpson JL; Nelson LM
    Fertil Steril; 2007 Mar; 87(3):456-65. PubMed ID: 17074338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive-behavioral profiles of females with the fragile X mutation.
    Fisch GS
    Am J Med Genet A; 2006 Apr; 140(7):673-7. PubMed ID: 16477608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
    Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological and endocrine phenotypes of fragile X carrier women.
    Hall D; Todorova-Koteva K; Pandya S; Bernard B; Ouyang B; Walsh M; Pounardjian T; Deburghraeve C; Zhou L; Losh M; Leehey M; Berry-Kravis E
    Clin Genet; 2016 Jan; 89(1):60-7. PubMed ID: 26212380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
    Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ
    JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and mathematics: FMR1 premutation female carriers.
    Semenza C; Bonollo S; Polli R; Busana C; Pignatti R; Iuculano T; Maria Laverda A; Priftis K; Murgia A
    Neuropsychologia; 2012 Dec; 50(14):3757-63. PubMed ID: 23123760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premature ovarian failure: a phenotypic expression of fragile X premutation.
    Holoch K; Stein Q; Flanagan J; Hansen K
    S D Med; 2008 Jan; 61(1):13, 15. PubMed ID: 18323308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune mediated disorders in women with a fragile X expansion and FXTAS.
    Jalnapurkar I; Rafika N; Tassone F; Hagerman R
    Am J Med Genet A; 2015 Jan; 167A(1):190-7. PubMed ID: 25399540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.
    Gabis LV; Gruber N; Berkenstadt M; Shefer S; Attia OL; Mula D; Cohen Y; Elizur SE
    Cerebellum; 2016 Oct; 15(5):595-8. PubMed ID: 27312842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal GABA-mediated and cerebellar inhibition in women with the fragile X premutation.
    Conde V; Palomar FJ; Lama MJ; Martínez R; Carrillo F; Pintado E; Mir P
    J Neurophysiol; 2013 Mar; 109(5):1315-22. PubMed ID: 23236003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping self-reports of working memory deficits to executive dysfunction in Fragile X Mental Retardation 1 (FMR1) gene premutation carriers asymptomatic for FXTAS.
    Kogan CS; Cornish KM
    Brain Cogn; 2010 Aug; 73(3):236-43. PubMed ID: 20573435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragile X-associated disorders: a clinical overview.
    Gallagher A; Hallahan B
    J Neurol; 2012 Mar; 259(3):401-13. PubMed ID: 21748281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
    Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.